foxo4-dri for senescent cells 10mg | Senolytic Research Peptide Quantity:1 Vial research bundle Targeted immunotherapy rescues pulmonary
Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile | Nature Communications
Exosome treatments can be integrated to improve the appearance of fine lines, wrinkles, scars, and uneven skin tone, making them an advanced, non-invasive solution for healthier, glowing skin.
research bundle
Quantity:1 Vial
Chinolinium-Derivat, kein PeptidQuinolinium derivative, not a peptide Untersucht als selektiver NNMT-HemmerStudied as a selective NNMT inhibitor Iodidsalz mit 286,11 g/molIodide salt with 286.11 g/mol Chargenbezogener AnalysenberichtBatch-matched certificate of analysis Versiegelt und verbördeltSealed and crimped Versand in die gesamte EUShips across the EU AnalysezertifikatCertificate of Analysis 5-Amino-1MQ · 50 mg COA-ChargeCOA batch GUP-50AM-20260819 Zertifikat zur Vial-ProbeCertificate for the vial sample Chemischer NameChemical name 5-Amino-1-methylchinoliniumiodid5-Amino-1-methylquinolinium iodide ReinheitPurity siehe Chargenberichtsee batch report CAS-NummerCAS Number 42464-96-042464-96-0 MolekülformelMolecular formula C₁₀H₁₁IN₂C₁₀H₁₁IN₂ MolekulargewichtMolecular weight 286,11 g/mol (Iodidsalz)286.11 g/mol (iodide salt) WirkmechanismusMechanism NNMT-HemmerNNMT inhibitor FormPhysical form Lyophilisiertes PulverLyophilized powder NettomengeNet quantity 50 mg pro Vial50 mg per vial KategorieCategory ForschungschemikalieResearch chemical LagerungStorage Gemäß Etikett und ChargendokumentationAccording to label and batch documentation LichtschutzLight protection Vor direktem Licht schützenProtect from direct light SKUSKU GUP-50AMGUP-50AM 5-Amino-1MQ — selektiver NNMT-Hemmer5-Amino-1MQ — Selective NNMT Inhibitor 5-Amino-1MQ ist kein Peptid, sondern ein niedermolekularer Hemmstoff der Nicotinamid-N-Methyltransferase (NNMT)